SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-025896 from CalciMedica, Inc. (CALC)

CalciMedica, Inc.
Date: Feb. 7, 2024 · CIK: 0001534133 · Accession: 0001193125-24-025896

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-276793

Date
February 7, 2024
Author
A. Rachel Leheny, Ph.D.
Form
CORRESP
Company
CalciMedica, Inc.

Letter

CALCIMEDICA, INC.

505 Coast Boulevard South, Suite 307

La Jolla, CA 92037

February 7, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Mr. Tyler Howes

RE: CalciMedica, Inc.

Registration Statement on Form S-3

File No. 333-276793

Ladies and Gentlemen:

CalciMedica, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on February 9, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP and Brittany Wightman of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at (858) 550-6157, or in his absence, Brittany Wightman of Cooley LLP at (858) 550-6132.

Very truly yours,
CALCIMEDICA, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 CALCIMEDICA, INC.

505 Coast Boulevard South, Suite 307

La Jolla, CA 92037

 February 7, 2024

 VIA EDGAR

 United States Securities and Exchange
Commission

 Division of Corporation Finance

 100 F Street,
N.E.

 Washington, D.C. 20549

 Attn: Mr. Tyler Howes

RE:
 CalciMedica, Inc.

Registration Statement on Form S-3

File No. 333-276793

Ladies and Gentlemen:

CalciMedica, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the
“Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on February 9, 2024, at 4:00 p.m., Eastern Time, or as
soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP and Brittany Wightman of Cooley
LLP, counsel to the Registrant, to make such request on its behalf.

 Once the Registration Statement has been declared effective, please
orally confirm that event with Carlos Ramirez at (858) 550-6157, or in his absence, Brittany Wightman of Cooley LLP at (858) 550-6132.

Very truly yours,

 CALCIMEDICA, INC.

By:

/s/ A. Rachel Leheny

Name:

A. Rachel Leheny, Ph.D.

Title:

Chief Executive Officer

cc:
 John Dunn, CalciMedica, Inc.

 
 Carlos Ramirez, Cooley LLP

 
 Brittany Wightman, Cooley LLP